Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE II)

← Back to all studies

Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE II)

Health Condition: Hematology (Sickle Cell)
Health Impact Domain: -

Summary

Sickle cell disease is an inherited blood disorder affecting approximately 90,000 people in the United States, of whom 36,000 are children. The sickling of abnormal hemoglobin in red blood cells contributes to inflammation and pain resulting in people with SCD having high rates of ED visits and hospitalizations. Acute care utilization rates in SCD are amongst the highest of any disease, are commonly due to painful vaso-occlusive crises (VOC), and are associated with high admission and readmission rates. Successful adherence to guidelines for VOC care has the potential to significantly impact the health and well-being of patients with SCD and improve their health outcomes.

Key Publications

Related Media

-

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.